Regis Bescond

Regis Bescond has extensive work experience as a Controller and Manager in various companies. Regis currently serves as the Corporate Controller at ALOM, a position they have held since 2023. Prior to that, they worked as the Corporate Controller at Inflammatix, Inc. from 2020 to 2023. In this role, they were responsible for worldwide close process, audit, forecasting process, and managing the international tax structure.

Before joining Inflammatix, Inc., Regis worked as the Division Controller at Teradyne from 2010 to 2020. In this role, they were responsible for the division's worldwide close process, revenue accounting, and international compliance. Regis also managed the international tax structure and was involved in manufacturing transfer and compliance with China trade restrictions.

From 2008 to 2010, Regis served as the Corporate Controller at Amlogic, Inc., where they oversaw the worldwide close process, international tax compliance, and research for international tax issues. Regis also led the IPO planning effort for the company.

Prior to that, Regis worked at Ikanos Communications from 2006 to 2008 as the Corporate Controller. In this role, they managed the close process, supervised international inter-company transactions, and led the Sarbanes Oxley implementation and compliance.

Regis also has experience as the Corporate Controller at IntraOp Medical Corporation from 2005 to 2006, as the Accounting Manager at Ikanos Communications from 2003 to 2005, as the Plant Controller and Corporate Controller at Johnson & Johnson from 1999 to 2003, as the Accounting Manager at VIRTUAL VISITS in 1999, and as the Accounting Supervisor at eMachines from 1996 to 1999.

Regis Bescond obtained a Master of Business Administration (MBA) degree with a focus on Accounting and Finance from California State University - East Bay. This academic achievement took place from 1992 to 1994.